Earnings History Data for AgeX Therapeutics, Inc. (AGE) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
AgeX Therapeutics, Inc.
AgeX Therapeutics Inc. is involved in the development and commercialization of novel therapeutics targeting human aging. The company's proprietary technology consists of PureStem(R) and Tissue Regeneration(TM). Its product pipeline includes AGEX-VASC1, AGEX-BAT1, AGEX-iTR1547 and Renelon(TM). AgeX Therapeutics Inc. is based in Alameda, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10-11-2022 | AH | AGE | AgeX Therapeutics, Inc. | 24.49 | -0.06 | 0.00 | -0.05 | AgeX Therapeutics GAAP EPS of -$0.06, revenue of $9M [11/10/2022 5:11 PM] |
0.6101 | 0.04 (6.28%) |
0.57 | 0.0 (0.00%) |
0.52 - 1.39 | 8,688 | 20,000 | 100 | ||
| 13-05-2022 | AH | 4:05 PM ET (May 13) |
AGE | AgeX Therapeutics, Inc. | 26.57 | -0.07 | 0.00 | -0.05 | AgeX Therapeutics GAAP EPS of -$0.07 [5/13/2022 4:20 PM] |
0.7010 | -0.05 (-6.53%) |
0.0 | 0.0 (0.00%) |
0.52 - 1.77 | 10,344 | 50,000 | 0 | |
| 29-03-2022 | AH | After the close (Mar 29) |
AGE | AgeX Therapeutics, Inc. | 33.37 | N/A | 0.00 | -0.07 | AgeX Therapeutics GAAP EPS of -$0.23, revenue of $0.14M [3/29/2022 4:51 PM] |
0.9141 | 0.01 (0.86%) |
0.0 | 0.0 (0.00%) |
0.52 - 1.78 | 70,354 | 50,000 | 0 | |
| 12-11-2021 | AH | AGE | AgeX Therapeutics, Inc. | 31.06 | -0.05 | 0.00 | -0.07 | AgeX Therapeutics reports Q3 results [11/12/2021 4:10 PM] |
0.8084 | 0.0 (-0.19%) |
0.81 | 0.0 (0.00%) |
0.79 - 3.06 | 113,336 | 110,000 | 6,096 | ||